Related Experiment Video
Updated: Jun 21, 2026
13:44
A Method for High Fidelity Optogenetic Control of Individual Pyramidal Neurons In vivo
Published on: September 2, 2013
Optogenetic control of epileptiform activity.
Jan Tønnesen1, Andreas T Sørensen, Karl Deisseroth
1Experimental Epilepsy Group, Division of Neurology, Wallenberg Neuroscience Center, Lund University Hospital, 221 00 Lund, Sweden.
Summary
Optogenetics using Natronomonas pharaonis halorhodopsin (NpHR) can inhibit neuronal hyperexcitability and epileptiform activity. This approach shows potential for developing new epilepsy treatments by controlling neuronal firing.
Area of Science:
- Neuroscience
- Optogenetics
- Molecular Biology
Background:
- Optogenetics offers control over neuronal excitability for research and therapeutic development.
- Neurologic conditions like epilepsy involve excessive neuronal hyperexcitability.
Purpose of the Study:
- To investigate if the Natronomonas pharaonis halorhodopsin (NpHR) optogenetic tool can inhibit hyperexcitability and epileptiform activity.
- To assess NpHR's efficacy in hyperpolarizing central neurons within the mammalian central nervous system (CNS).
Main Methods:
- Utilized a lentiviral vector to deliver the NpHR gene into hippocampal and cortical principal cells.
- Employed optical stimulation to activate NpHR and induce neuronal hyperpolarization.
- Tested NpHR's effect on epileptiform activity in hippocampal organotypic slice cultures.
Main Results:
- NpHR successfully transduced and hyperpolarized principal neurons in the hippocampus and cortex.
- Optical stimulation of NpHR-expressing neurons prevented action potential generation and epileptiform activity.
- NpHR inhibited stimulation train-induced bursting in a model of pharmacoresistant epilepsy.
Conclusions:
- Selective hyperpolarization of cortical neurons via NpHR effectively curtails paroxysmal activity.
- Optogenetic control using NpHR demonstrates therapeutic potential for managing epileptiform discharges.
- This study supports NpHR as a promising strategy for future epilepsy treatment development.
